Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?

被引：0
|
作者：
Kim, S. [1 ]
Kang, D. H. [1 ,2 ]
Lee, J. H.
Cho, W. S. [1 ]
Jeung, Y. I. [1 ]
Park, J. H. [2 ]
Jeung, K. S. [3 ]
机构：
[1] Pusan Natl Univ, Yangsan Hosp, Pusan, South Korea
[2] Pusan Bongsaeng Hosp, Pusan, South Korea
[3] Jinju Korea Hosp, Jinju, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：196 / 197
页数：2
相关论文
共 50 条
  • [1] Is High-Dose Nafamostat Mesilate Effective for the Prevention of Post-ERCP Pancreatitis, Especially in High-Risk Patients?
    Park, Kee Tae
    Kang, Dae Hwan
    Choi, Cheol Woong
    Cho, Mong
    Park, Su Bum
    Kim, Hyung Wook
    Kim, Dong Uk
    Chung, Chung Wook
    Yoon, Ki Tae
    PANCREAS, 2011, 40 (08) : 1215 - 1219
  • [2] Is High-Dose Nafamostat Mesilate Effective For The Prevention of Post-ERCP Pancreatitis, Especially in High-Risk Patients?
    Kang, D. H.
    Choi, C. W.
    Park, S. B.
    Kim, H. W.
    Park, J. H.
    Kim, M. D.
    PANCREAS, 2012, 41 (08) : 1374 - 1374
  • [3] Nafamostat mesilate for prevention of Post-ERCP pancreatitis
    Yoo, Kyo-Sang
    Moon, Joon Ho
    Park, Kwang Hyuk
    Chung, Yong Woo
    Kim, Kyoung Oh
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Lee, Jin
    Park, Choong Kee
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB212 - AB212
  • [4] Nafamostat mesilate for prevention of post-ERCP pancreatitis
    Ybo, Kyo-Sang
    Choi, Won Sub
    Chung, Woo
    Kim, Kyourig On
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Lee, Jin
    Park, Choong Kee
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB153 - AB153
  • [5] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [6] PREVENTION OF POST-ERCP PANCREATITIS IN HIGH-RISK PATIENTS
    Turovets, Mikhail
    Popov, Alexander
    Mandrikov, Viktor
    Vedenin, Yury
    Ekstrem, Andrej
    ARCHIV EUROMEDICA, 2021, 11 (02): : 72 - 77
  • [7] Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang Ha
    Eum, Jae Sup
    Lee, Sun Mi
    Song, Geun Am
    Kim, Dong Uk
    Kim, Il Doo
    Cho, Mong
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) : E11 - E18
  • [8] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Joo Seong Kim
    Sang Hyub Lee
    Namyoung Park
    Gunn Huh
    Jung Won Chun
    Jin Ho Choi
    In Rae Cho
    Woo Hyun Paik
    Ji Kon Ryu
    Yong-Tae Kim
    BMC Gastroenterology, 22
  • [9] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, J. S.
    Lee, S. H.
    Park, N.
    Huh, G.
    Chun, J. W.
    Choi, J. H.
    Cho, I. R.
    Paik, W. H.
    Ryu, J. K.
    Kim, Y. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 134 - 134
  • [10] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, Joo Seong
    Lee, Sang Hyub
    Park, Namyoung
    Huh, Gunn
    Chun, Jung Won
    Choi, Jin Ho
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    BMC GASTROENTEROLOGY, 2022, 22 (01)
12345